Literature DB >> 1324741

Incidence and histological features of bone marrow involvement in malignant lymphomas.

G Lambertenghi-Deliliers1, C Annaloro, D Soligo, A Oriani, E Pozzoli, N Quirici, R Luksch, E E Polli.   

Abstract

Bone marrow biopsy (BMB) is a routine investigation in the diagnosis and staging of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL), and there is evidence supporting its prognostic importance in some histological varieties. The histological characteristics of BMB in 433 NHL and 155 HD patients were reviewed for clinicopathological correlations; 36 of these cases were also studied by means of immunohistochemistry. BM infiltrates were discovered in 171 NHL patients. In 36 cases, the diagnosis of NHL was directly established by BMB; a discordance between lymph node and BM histology was observed in 38 of the other 135 cases. BM-positive centroblastic and immunoblastic NHL were significantly associated with larger infiltrates, BM fibrosis, and megakaryocytic hyperplasia. Leukemization at diagnosis was more frequent in low-malignancy NHL. No correlation was found between histology and prognosis, although immunohistochemistry revealed a B-cell phenotype in all but two cases. BMB was positive in 18 of the 155 HD patients and directly diagnostic in two; Reed-Sternberg and Hodgkin cells were CD-30 positive and surrounded by T-cell infiltration. The concordance between BM and lymph node histology was fairly satisfactory, although the relationships between BM infiltration and other histological parameters may reflect peculiar interactions with BM microenvironmental factors. The usefulness of BMB in the diagnosis of malignant lymphomas has been demonstrated, and further progress can be expected from the availability of reliable immunohistochemical markers of clonality reacting on paraffin-embedded BM sections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324741     DOI: 10.1007/bf01698130

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  20 in total

1.  In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study.

Authors:  H P Horny; U Engst; R S Walz; E Kaiserling
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

2.  Lymphoproliferations in the bone marrow: identification and evolution, classification and staging.

Authors:  R Bartl; B Frisch; R Burkhardt; K Jäger; R Pappenberger; G Hoffmann-Fezer
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

3.  Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.

Authors:  M G Conlan; M Bast; J O Armitage; D D Weisenburger
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

Review 4.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

5.  The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.

Authors:  J M Bennett; K C Cain; J H Glick; G J Johnson; E Ezdinli; M J O'Connell
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

6.  Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.

Authors:  K Foucar; R W McKenna; G Frizzera; R D Brunning
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

7.  Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria.

Authors:  M E Ellis; L F Diehl; E Granger; E Elson
Journal:  Am J Hematol       Date:  1989-03       Impact factor: 10.047

8.  Stage IV diffuse large-cell lymphoma: a long-term analysis.

Authors:  S Jagannath; W S Velasquez; S L Tucker; J T Manning; P McLaughlin; L M Fuller
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

9.  Frequent biclonality and Ig gene alterations among B cell lymphomas that show multiple histologic forms.

Authors:  M H Siegelman; M L Cleary; R Warnke; J Sklar
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  Bone marrow involvement at onset of Hodgkin's disease.

Authors:  G Cimino; A P Anselmo; A M De Luca; P Fidani; F Mauro; A Marzullo; R Maurizi Enrici; G Papa
Journal:  Tumori       Date:  1983-02-28
View more
  5 in total

Review 1.  The bone marrow stroma in hematological neoplasms--a guilty bystander.

Authors:  Claudio Tripodo; Sabina Sangaletti; Pier P Piccaluga; Sonam Prakash; Giovanni Franco; Ivan Borrello; Attilio Orazi; Mario P Colombo; Stefano A Pileri
Journal:  Nat Rev Clin Oncol       Date:  2011-03-29       Impact factor: 66.675

2.  A unique bone marrow lymphoma patient presenting with an isolated mass: A case report.

Authors:  Yi-Wen Xu; Ming-Hui Duan
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

3.  Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.

Authors:  J Thiele; T K Zirbes; H M Kvasnicka; R Fischer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

Review 4.  Primary multifocal osseous Hodgkin disease: a case report and review of the literature.

Authors:  C Gebert; J Hardes; H Ahrens; H Buerger; W Winkelmann; G Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-15       Impact factor: 4.553

5.  Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China.

Authors:  Yun-Fei Shi; Xiang-Hong Li; Yu-Qin Song; Wei-Wei Song; Yu-Mei Lai
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.